NCT07211048 2026-01-21
Anti CD19 Gene Therapy for B-cell Lymphoma
Anhui Provincial Hospital
Phase NA Recruiting
Clinical Trials
20 trialsNCT07135466 2026-01-16
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Recruiting
NCT06520163 2025-12-04
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT07258043 2025-12-02
EPOCH
Hospital General de Mexico
Recruiting
NCT06409767 2025-09-24
ALHERT
University Hospital, Angers
Phase NA Recruiting
NCT06795815 2025-06-12
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
Phase NA Recruiting
NCT06793410 2025-06-05
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Vastra Gotaland Region
Phase 2 Recruiting
NCT06961669 2025-05-29
ECAR01
Anhui Provincial Hospital
Phase NA Recruiting
NCT04263935 2025-04-23
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Henan Cancer Hospital
Recruiting
NCT02964858 2025-04-11
DOBL
Tata Memorial Hospital
Phase NA Recruiting
NCT06299462 2025-02-25
PTCy and ATG for MSD and MUD Transplants
Instituto Nacional de Cancer, Brazil
Phase 1/2 Recruiting
NCT06822829 2025-02-12
REVERSE_2021
Azienda USL Reggio Emilia - IRCCS
Recruiting
NCT06307600 2025-01-23
The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
Anhui Provincial Hospital
Phase EARLY_PHASE1 Recruiting
NCT06758713 2025-01-06
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
The Third Affiliated Hospital of Southern Medical University
Phase 1 Recruiting
NCT05536154 2024-03-19
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Recruiting
NCT06056752 2023-10-24
QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Anhui Provincial Hospital
Phase 1 Recruiting
NCT05963347 2023-09-01
Go-CHOP as the Frontline Therapy for PTCL
Henan Cancer Hospital
Phase 2 Recruiting
NCT05982223 2023-08-08
Integrative Medicine in Lymphoma Survivors
Bnai Zion Medical Center
Phase NA Recruiting
NCT05648019 2023-03-09
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
KK Women's and Children's Hospital
Phase 2 Recruiting
NCT05528887 2022-09-06
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase 1 Recruiting